This means that the primary tumor has cells that use rhoA/ROCK signaling and undergo ameboid metastasis to lymphatics, as well as cells that use reactive oxygen/Akt signaling and undergo mesenchymal hematogenous metastasis to distant sites. The gene discussed is AKT1; the disease is neoplasm.